Syros Pharmaceuticals Inc (NAS:SYRS)
$ 1.5675 -0.035 (-2.18%) Market Cap: 42.02 Mil Enterprise Value: 24.59 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 38/100

Syros Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 01, 2023 / 01:00PM GMT
Release Date Price: $3.7 (-3.90%)
Operator

Hello, and welcome to the Annual Meeting of Stockholders of Syros Pharmaceuticals, Inc. Please note that today's meeting is being recorded. It is now my pleasure to turn today's meeting over to Gerald Quirk, Chief Legal Officer and Secretary of Syros. Mr. Quirk, the floor is yours.

Gerald E. Quirk
Syros Pharmaceuticals, Inc. - Chief Legal Officer

Thanks, Michelle. Good morning, ladies and gentlemen, and welcome to the 2023 Annual Meeting of Stockholders of Syros Pharmaceuticals. I'm Gerald Quirk, Chief Legal Officer and Company Secretary of Syros and at the direction of the Chair of the Board of Directors, I will be presiding over this meeting. At this time, I call the meeting to order. I have received an affidavit from our transfer agent, Computershare, certifying that the notice of the annual meeting and proxy statement were sent to all stockholders of record as of April 4, 2023, a copy of which will be included in the minutes of this meeting.

Our first order of business at the meeting is to determine whether the shares represented at the meeting,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot